Amylx Pharmaceuticals Inc vs Goodyear Tire & Rubber Co — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Goodyear Tire & Rubber Co trades at $6.12 (market cap $1.75B). The key difference: Amylx Pharmaceuticals Inc is the larger of the two by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals.
| AMLX | GT | |
|---|---|---|
Market Cap | $2.64B | $1.75B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $10.54 |
52-Week Low | $7.82 | $5.58 |
Enterprise Value | $2.39B | $9.11B |
Trailing returns across standard periods
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →